Abstract: A measuring device comprising: a sensor (1) with at least one electromechanical transducer (10); at least one electrical generator connected to said transducer; and means for measuring the electrical input impedance of the transducer. Said sensor (1) has an empty space (12) passing therethrough within which a substance (14) can flow, and said transducer (10) is situated at the periphery of said empty space (12) in such a manner as to be subjected to a mechanical load characteristic of the substance (14) flowing in said space (12), the measured electrical impedance being a function of said load. The device is suitable for use in a measuring apparatus seeking to determine the density of the substance (14) flowing inside said tubular space (12).

Abstract: A measuring device comprising: a sensor (1) with at least one electromechanical transducer (10); at least one electrical generator connected to said transducer; and means for measuring the electrical input impedance of the transducer. Said sensor (1) has an empty space (12) passing therethrough within which a substance (14) can flow, and said transducer (10) is situated at the periphery of said empty space (12) in such a manner as to be subjected to a mechanical load characteristic of the substance (14) flowing in said space (12), the measured electrical impedance being a function of said load. The device is suitable for use in a measuring apparatus seeking to determine the density of the substance (14) flowing inside said tubular space (12).

Abstract: The present invention relates generally to methods and compositions for treating a disease or condition by administering a first therapeutic protocol comprising targeting and delivering solid-phase platelet-dependent vascular occlusion agents, and administering at least one second therapeutic composition or method.

Abstract: The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks; the solid-phase agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the rapid formation of a platelet-mediated thrombus about the solid-phase agent causing vessel occlusion.

Abstract: The present invention relates generally to methods and compositions for targeting, delivering, and activating platelet-dependent vascular occlusion agents. In particular, antibodies carrying platelet binding agents are targeted to hyperplastic cells or tissues, such as the vasculature of solid tumor masses; the platelet binding agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the formation of a platelet-mediated thrombus-causing vessel occlusion.

Abstract: The present invention relates generally to methods and compositions for targeting, delivering, and activating platelet-dependent vascular occlusion agents. In particular, fusion proteins carrying platelet binding agents are targeted to hyperplastic cells or tissues, such as the vasculature of solid tumor masses; the platelet binding agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the formation of a platelet-mediated thrombus-causing vessel occlusion.